The Associations of Muscle Strength, Muscle Mass, and Adiposity With Clinical Outcomes and Quality of Life in Prevalent Kidney Transplant Recipients

被引:46
|
作者
Chan, Winnie [1 ,2 ,3 ]
Chin, Shui Hao [4 ]
Whittaker, Anna C. [3 ,5 ]
Jones, David [6 ]
Kaur, Okdeep [1 ]
Bosch, Jos A. [3 ,7 ]
Borrows, Richard [1 ,8 ]
机构
[1] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Dept Nephrol & Kidney Transplantat, Area 5,Level 7, Birmingham, W Midlands, England
[2] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Dept Nutr & Dietet, Therapy Serv South Suite,1st Floor,Mindelsohn Way, Birmingham B15 2WB, W Midlands, England
[3] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England
[4] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England
[5] Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland
[6] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester, Lancs, England
[7] Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands
[8] Univ Birmingham, Ctr Translat Inflammat Res, Birmingham, W Midlands, England
关键词
URINARY CREATININE EXCRETION; HANDGRIP STRENGTH; RENAL-TRANSPLANT; BODY-COMPOSITION; SKELETAL-MUSCLE; GRIP STRENGTH; VITAMIN-D; MUSCULAR STRENGTH; SARCOPENIA; MORTALITY;
D O I
10.1053/j.jrn.2019.06.009
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: Sarcopenia, defined as loss of both muscle strength and mass, is associated with inferior clinical outcomes and quality of life (QoL) in chronic kidney disease, but its effects are unknown in kidney transplantation. Obesity confers increased mortality risk and compromises QoL in kidney transplant recipients (KTRs), but the impacts of sarcopenic obesity remain unexplored. This study aimed to evaluate the associations of muscle strength and mass, sarcopenia, and sarcopenic obesity with clinical outcomes and QoL in KTRs. Methods: This prospective longitudinal study enrolled 128 KTRs >= 1-year posttransplantation. Low muscle strength (by handgrip strength) and mass (by bioimpedance analysis), and a combination of both (sarcopenia) were defined as < reference cutoffs for corresponding indices. Sarcopenic obesity was defined as sarcopenia combined with fulfillment of >= 2 out of 3 criteria from (1) body mass index >= 30 kg/m(2), (2) bioimpedance analysis-derived fat mass > reference cutoffs, and (3) waist circumference > World Health Organization cutoffs. Prospective follow-up data on mortality and hospitalization were collected. QoL was evaluated using Medical Outcomes Study Short Form-36 questionnaire. Results: Median follow-up duration was 64 (60-72) months. Low muscle strength was independently associated with the composite endpoint of mortality and hospitalization (hazard ratio = 2.45; P = .006), and QoL (physical-related: beta = -12.2; P = .04; mental-related: beta = -9.9; P = .04). Low muscle mass (beta = -8.8; P = .04) and sarcopenia (beta = -14.7; P = .03) were associated with physical-related QoL only. No independent associations were found between muscle mass, sarcopenia, and sarcopenic obesity with the composite outcome of mortality and hospitalization. Conclusion: Low muscle strength is common among KTRs, conferring poor prognosis in the medium term. Future research on strength training may prove valuable in improving kidney transplantation outcomes. (C) 2019 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:536 / 547
页数:12
相关论文
共 50 条
  • [31] Impedance-derived phase angle is associated with muscle mass, strength, quality of life, and clinical outcomes in maintenance hemodialysis patients
    Kang, Seok Hui
    Do, Jun Young
    Kim, Jun Chul
    PLOS ONE, 2022, 17 (01):
  • [32] Muscle strength as a marker of metabolic health in kidney transplant recipients: A cross-sectional study
    Ibagon, Jhonatan Camilo Pena
    Pinto, Edith Martin
    Morales, Carlos Andres Collazos
    Rojas-Valverde, Daniel
    Cardozo, Luis Alberto
    Pardo, Yordan Rene
    Martin, William Felipe
    Pena, Cristian Camilo
    JOURNAL OF BODYWORK AND MOVEMENT THERAPIES, 2024, 40 : 1979 - 1984
  • [33] Association Between Serum Prealbumin Level and Outcomes in Prevalent Kidney Transplant Recipients
    Gaipov, Abduzhappar
    Jackson, Christopher D.
    Talwar, Manish
    Balaraman, Vasanthi
    Chakravarty, Arijit
    Cseprekal, Orsolya
    Mathe, Zoltan
    Remport, Adam
    Kovesdy, Csaba P.
    Eason, James D.
    Mucsi, Istvan
    Molnar, Miklos Z.
    JOURNAL OF RENAL NUTRITION, 2019, 29 (03) : 188 - 195
  • [34] Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes
    Leong, Darryl P.
    Fradet, Vincent
    Niazi, Tamim
    Selvanayagam, Joseph B.
    Sabbagh, Robert
    Higano, Celestia S.
    Agapay, Steven
    Rangarajan, Sumathy
    Mian, Rajibul
    Nakashima, Carlos A. K.
    Mousavi, Negareh
    Brown, Ian
    Valle, Felipe H.
    Lavallee, Luke T.
    Shayegan, Bobby
    Ng, Kelvin K. H.
    Gopaul, Darin D.
    Cavalli, Germano D.
    Saavedra, Sonia
    Lopez-Lopez, Jose P.
    de Souza, Cristiano Freitas
    Duceppe, Emmanuelle
    Oliveira, Livia F. Avezum
    Guha, Avirup
    Gomez-Mesa, Juan Esteban
    Moz, Luis Eduardo Silva
    Violette, Philippe D.
    Avezum, Alvaro
    Oliveira, Gustavo B. F.
    Kann, Ariel G.
    Walter, Edilson
    Dusilek, Cesar O. L.
    Trujillo, Nicolas Villareal
    Beato, Patricia
    Hajjar, Ludhmila A.
    Luke, Patrick P. W.
    Schlabendorff, Eduardo
    Sarid, David
    Pinthus, Jehonathan
    JACC: CARDIOONCOLOGY, 2024, 6 (05): : 761 - 771
  • [35] The creatinine/cystatin C ratio provides effective evaluation of muscle mass in kidney transplant recipients
    Yanishi, Masaaki
    Kinoshita, Hidefumi
    Tsukaguchi, Hiroyasu
    Kimura, Yutaka
    Koito, Yuya
    Sugi, Motohiko
    Matsuda, Tadashi
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (01) : 79 - 83
  • [36] The creatinine/cystatin C ratio provides effective evaluation of muscle mass in kidney transplant recipients
    Masaaki Yanishi
    Hidefumi Kinoshita
    Hiroyasu Tsukaguchi
    Yutaka Kimura
    Yuya Koito
    Motohiko Sugi
    Tadashi Matsuda
    International Urology and Nephrology, 2019, 51 : 79 - 83
  • [37] SKELETAL-MUSCLE STRENGTH IN HEART-TRANSPLANT RECIPIENTS
    BRAITH, RW
    LIMACHER, MC
    LEGGETT, SH
    POLLOCK, ML
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1993, 12 (06): : 1018 - 1023
  • [38] Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients
    Palanisamy, Arun P.
    Al Manasra, Abdel R.
    Pilch, Nicole A.
    Dowden, Jacob E.
    Nadig, Satish N.
    McGillicuddy, John W.
    Baliga, Prabakar K.
    Chavin, Kenneth D.
    Taber, David J.
    CLINICAL TRANSPLANTATION, 2015, 29 (03) : 222 - 226
  • [39] THE QUALITY OF LIFE OF KIDNEY AND HEART-TRANSPLANT RECIPIENTS
    EVANS, RW
    MANNINEN, DL
    MAIER, A
    GARRISON, LP
    HART, LG
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (01) : 1579 - 1582
  • [40] Associations of pyrethroid exposure with skeletal muscle strength and mass
    Zhenger Fang
    Xia Chen
    Mingliang Liu
    Lei Zuo
    Biying Zhou
    Guangjun Zheng
    Haiyan Chen
    Guang Hao
    Environmental Science and Pollution Research, 2023, 30 : 89651 - 89660